This is a synthetic peptide designed for use in combination with anti-PLA2G2E Antibody(ARP47041_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PLA2G2E
(Phospholipase A2, Group IIE (PLA2G2E))
Synonyme
GIIE sPLA2 Peptide, sPLA2-IIE Peptide, phospholipase A2 group IIE Peptide, phospholipase A2, group IIE Peptide, PLA2G2E Peptide, Pla2g2e Peptide
Hintergrund
PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.PLA2G2E has a preference for arachidonic-containing phospholipids.